Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 108

1.

Venous thromboembolism in patients with liver diseases.

Barba R, Gonzalvez Gashc A, Seijo DJ, Marco J, Canora J, Plaza S, Angelina García M, Zapatero A.

J Thromb Haemost. 2018 Aug 1. doi: 10.1111/jth.14255. [Epub ahead of print]

PMID:
30066476
2.

Usefulness of the KDPI in Spain: A comparison with donor age and definition of standard/expanded criteria donor.

Arias-Cabrales C, Pérez-Sáez MJ, Redondo-Pachón D, Buxeda A, Burballa C, Bermejo S, Sierra A, Mir M, Burón A, Zapatero A, Crespo M, Pascual J.

Nefrologia. 2018 Jun 5. pii: S0211-6995(18)30067-5. doi: 10.1016/j.nefro.2018.03.003. [Epub ahead of print] English, Spanish.

3.

Severe vitamin D deficiency upon admission in critically ill patients is related to acute kidney injury and a poor prognosis.

Zapatero A, Dot I, Diaz Y, Gracia MP, Pérez-Terán P, Climent C, Masclans JR, Nolla J.

Med Intensiva. 2018 May;42(4):216-224. doi: 10.1016/j.medin.2017.07.004. Epub 2017 Aug 26. English, Spanish.

4.

Reduced late urinary toxicity with high-dose intensity-modulated radiotherapy using intra-prostate fiducial markers for localized prostate cancer.

Zapatero A, Roch M, Büchser D, Castro P, Fernández-Banda L, Pozo G, Liñán O, Martin de Vidales C, Cruz-Conde A, García-Vicente F.

Clin Transl Oncol. 2017 Sep;19(9):1161-1167. doi: 10.1007/s12094-017-1655-9. Epub 2017 Apr 3.

PMID:
28374321
5.

Erratum to: Procedures and recommended times in the care process of the patient with pancreatic cancer: PAN-TIME consensus between scientific societies.

Vera R, Ferrández A, Ferrer CJ, Flores C, Joaquín C, López S, Martín T, Martín E, Marzo M, Sarrión A, Vaquero E, Zapatero A, Aparicio J.

Clin Transl Oncol. 2017 Sep;19(9):1173. doi: 10.1007/s12094-017-1636-z. No abstract available.

6.

Procedures and recommended times in the care process of the patient with pancreatic cancer: PAN-TIME consensus between scientific societies.

Vera R, Ferrández A, Ferrer CJ, Flores C, Joaquín C, López S, Martín T, Martín E, Marzo M, Sarrión A, Vaquero E, Zapatero A, Aparicio J.

Clin Transl Oncol. 2017 Jul;19(7):834-843. doi: 10.1007/s12094-016-1609-7. Epub 2017 Jan 19. Erratum in: Clin Transl Oncol. 2017 Sep;19(9):1173.

7.

Prospective validation of right ventricular role in primary graft dysfunction after lung transplantation.

Pérez-Terán P, Roca O, Rodríguez-Palomares J, Ruiz-Rodríguez JC, Zapatero A, Gea J, Serra J, Evangelista A, Masclans JR.

Eur Respir J. 2016 Dec;48(6):1732-1742. doi: 10.1183/13993003.02136-2015. Epub 2016 Oct 6.

8.

Late Radiation and Cardiovascular Adverse Effects After Androgen Deprivation and High-Dose Radiation Therapy in Prostate Cancer: Results From the DART 01/05 Randomized Phase 3 Trial.

Zapatero A, Guerrero A, Maldonado X, Álvarez A, González-San Segundo C, Cabeza Rodriguez MA, Macías V, Pedro Olive A, Casas F, Boladeras A, Martín de Vidales C, Vázquez de la Torre ML, Calvo FA.

Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2):341-348. doi: 10.1016/j.ijrobp.2016.06.2445. Epub 2016 Jun 22.

PMID:
27598804
9.

High Flow Therapy in Post-Lung Transplant Patients.

Masclans JR, Zapatero A, Sacanell J.

Arch Bronconeumol. 2017 Apr;53(4):182-183. doi: 10.1016/j.arbres.2016.07.014. Epub 2016 Aug 22. English, Spanish. No abstract available.

10.

Mucormycosis: an unusual cause of gastric perforation and severe bleeding in immunocompetent patients.

Sánchez Velázquez P, Pera M, Gimeno J, Zapatero A, Nolla J, Pera M.

Rev Esp Enferm Dig. 2017 Mar;109(3):223-225. doi: 10.17235/reed.2016.4269/2016.

11.

Corrigendum to "Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance". [Rep. Pract. Oncol. Radiother. 20 (2015) 259-272].

López Torrecilla J, Hervás A, Zapatero A, Gómez Caamaño A, Macías V, Herruzo I, Maldonado X, Gómez Iturriaga A, Casas F, González San Segundo C.

Rep Pract Oncol Radiother. 2016 Jan-Feb;21(1):90-2. doi: 10.1016/j.rpor.2015.06.006. Epub 2015 Jul 20.

12.

Prevalence, Clinical Characteristics, and Risk Factors for Non-recording of Alcohol Use in Hospitals across Europe: The ALCHIMIE Study.

Rosón B, Corbella X, Perney P, Santos A, Stauber R, Lember M, Arutyunov A, Ruza I, Vaclavik J, García L, Pujol R, Stauber R, Vogel W, Vaclavik J, Gajdová J, Smrzova A, Liberdová A, Cibickova L, Plasek J, Svarcova T, Salupere R, Lember M, Rosón B, Guillem MN, Fernández-Sola J, Zapatero A, Monte R, Puerta RB, Gamallo R, Durán C, Perney P, Ouakli A, Oziol E, Bastide D, Tourneaire P, Allard G, Cros H, Piala JM, Quere I, Condouret S, Ruža I, Funka K, Zarina L, Barata J, Gonsalves O, Santos A, Oliveira N, Yakushin S, Petrovicheva L, Sleptsov A, Arutyunov A, Mitkhat G, Marusenko I; ALCHIMIE Study Group.

Alcohol Alcohol. 2016 Jul;51(4):457-64. doi: 10.1093/alcalc/agv142. Epub 2016 Jan 26.

PMID:
26818195
13.

Management of prostate cancer patients following radiation therapy after radical surgery referred from urology to radiation oncology departments in Spain.

Gómez Caamaño A, Zapatero A, López Torrecilla J, Maldonado X.

Clin Transl Oncol. 2016 Sep;18(9):884-92. doi: 10.1007/s12094-015-1454-0. Epub 2015 Nov 30.

PMID:
26621508
14.

Prolonged length of stay in hospitalized internal medicine patients.

Barba R, Marco J, Canora J, Plaza S, Juncos SN, Hinojosa J, Bailon MM, Zapatero A.

Eur J Intern Med. 2015 Dec;26(10):772-5. doi: 10.1016/j.ejim.2015.10.011. Epub 2015 Nov 10.

PMID:
26563937
15.

Prognostic Value of the Six-Second Spirometry in Patients with Chronic Obstructive Pulmonary Disease: A Cohort Study.

Prats E, Tejero E, Pardo P, Gavilán A, Galera R, Donado JR, Racionero MÁ, Casitas R, Zapatero A, García-Río F.

PLoS One. 2015 Oct 21;10(10):e0140855. doi: 10.1371/journal.pone.0140855. eCollection 2015.

16.

The frequency and impact of hypoglycemia among hospitalized patients with diabetes: A population-based study.

Gómez-Huelgas R, Guijarro-Merino R, Zapatero A, Barba R, Guijarro-Contreras A, Tinahones F, Bernal-López R.

J Diabetes Complications. 2015 Nov-Dec;29(8):1050-5. doi: 10.1016/j.jdiacomp.2015.07.018. Epub 2015 Jul 21.

PMID:
26279321
17.

Three linked nomograms for predicting biochemical failure in prostate cancer treated with radiotherapy plus androgen deprivation therapy.

López-Torrecilla J, Boladeras A, Cabeza MA, Zapatero A, Jove J, Esteban LM, Henriquez I, Casaña M, González-San Segundo C, Gómez-Caamaño A, Mengual JL, Hervás A, Muñoz JL, Sanz G.

Strahlenther Onkol. 2015 Oct;191(10):792-800. doi: 10.1007/s00066-015-0866-7. Epub 2015 Jul 9.

PMID:
26156249
18.

Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance.

López Torrecilla J, Hervás A, Zapatero A, Gómez Caamaño A, Macías V, Herruzo I, Maldonado X, Gómez Iturriaga A, Casas F, González San Segundo C.

Rep Pract Oncol Radiother. 2015 Jul-Aug;20(4):259-72. doi: 10.1016/j.rpor.2015.04.003. Epub 2015 May 30. Review. Erratum in: Rep Pract Oncol Radiother. 2016 Jan-Feb;21(1):90-2.

19.

Correction to Lancet Oncol 2015; 16: 324. High-dose radiotherapy with shortterm or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial.

Zapatero A, Guerrero A, Maldonado X.

Lancet Oncol. 2015 Jun;16(6):e262. doi: 10.1016/S1470-2045(15)70272-X. Epub 2015 May 27. No abstract available.

PMID:
26065609
20.

Reporting of results in DART01/05 GICOR - Author's reply.

Zapatero A.

Lancet Oncol. 2015 Jun;16(6):e258-9. doi: 10.1016/S1470-2045(15)70245-7. Epub 2015 May 27. No abstract available.

PMID:
26065605

Supplemental Content

Loading ...
Support Center